Health leaders warn that higher medicine costs linked to the UK–US pharmaceuticals agreement cannot simply be absorbed into local budgets.
Assessing Safety, Trust and Evidence as the NHS Moves Toward Automated Urgent-Care Triage
Why Regulators Intervened and What It Means for Patient Safety and Trust Leadership
Why Digital-First Care Could Widen Health Inequalities Without Urgent Action
Autumn Budget 2025: A Moment for Financial Reckoning for the UK
Dame Linda Pollard steps down immediately, citing personal reasons as concerns grow over stability in the system’s oversight bodies.
Bringing future DHSC funding into the present signals short term relief but exposes long term structural risks for NHS England and ICBs.
Why Delayed Diagnoses, Workforce Gaps and Diagnostic Bottlenecks Are Driving England’s Cancer Backlog
NHS Trust Executive insights reveal renewed confidence in NHS England’s CEO leadership and a clearer path to recovery.
